Stocks to Watch: Arch Coal Inc (NYSE:ACI), Clovis Oncology (NASDAQ:CLVS), 8×8 (NASDAQ:EGHT), Pier 1 Imports (NYSE:PIR), Jive Software Inc (NASDAQ:JIVE)

Arch Coal Inc. (NYSE:ACI) need to fix it all to protect shareholder value and its falling share prices. The Company won top Colorado awards during last month for its environmental friendly measures as well as workplace safety. However, the recent Environmental Protection Agency’s proposal to reduce carbon emission by cutting coal use and recent accusations of kickbacks taken by Arch Coal workers are potentially driving … Continue reading Stocks to Watch: Arch Coal Inc (NYSE:ACI), Clovis Oncology (NASDAQ:CLVS), 8×8 (NASDAQ:EGHT), Pier 1 Imports (NYSE:PIR), Jive Software Inc (NASDAQ:JIVE)

Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)

Aastrom Biosciences Inc (NASDAQ:ASTM) posted its quarterly earnings results on Thursday. The company reported ($1.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.34, AnalystRatings.NET reports. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of the company in a research note on Friday, March 14th. They now have a $5.00 price target on the … Continue reading Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)